tiprankstipranks

Cathal Friel Insider Profile

4 Followers
Cathal Friel, Director, Ten Percent Owner at Amryt Pharma, holds 45.97M shares in Open Orphan Plc (Ticker: GB:ORPH), holds 39.75M shares in Amryt Pharma (Ticker: GB:AMYT). Most recently, Cathal Friel Bought ― shares of Open Orphan Plc on Jan 31, 2020 for an estimated value of 300.00K.
tipranks
Cathal Friel

Cathal Friel
Amryt Pharma (AMYT)
Director, Ten Percent Owner

Ranked #9,471 out of 78,624 Corporate Insiders

Profitable Transactions

33%
1 out of 3 Profitable Transactions

Average Return

+91.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

£90M
87.26%
12.74%
A breakdown of Cathal Friel's holdings

Insider Roles

Amryt Pharma
(AMYT)
Director, Ten Percent Owner
Open Orphan Plc
(ORPH)
Chairman
Roles that Cathal Friel holds in companies

Most Profitable Insider Trade

Stock:
Open Orphan Plc
(ORPH)
Rating:Informative Buy
Date:Jan 31, 2020 - Jan 31, 2021
Return:+313.20%
The most profitable trade made by Cathal Friel

Cathal Friel's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Amryt Pharma
Jul 03, 2015
Director, Ten Percent Owner
Informative Buy
142.22K
£78.71M
Open Orphan Plc
Jan 31, 2020
Chairman
Informative Buy
300.00K
£11.49M
List of latest transactions for each holding click on a transaction to see Cathal Friel's performance on stock

Cathal Friel insider profile FAQ

What is the percentage of profitable transactions made by Cathal Friel?
The percentage of profitable transactions made by Cathal Friel is 33%.
    What is the average return per transaction made by Cathal Friel?
    The average return per transaction made by Cathal Friel is 91.40%.
      What stocks does Cathal Friel hold?
      Cathal Friel holds: GB:AMYT, GB:ORPH stocks.
        What was Cathal Friel’s latest transaction?
        Cathal Friel latest transaction was an Informative Buy of 300.00K.
          What was Cathal Friel's most profitable transaction?
          Cathal Friel’s most profitable transaction was an Informative Buy of GB:ORPH stock on January 31, 2020. The return on the trade was 313.20%.
            What is Cathal Friel's role in Amryt Pharma?
            Cathal Friel's role in Amryt Pharma is Director, Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.